Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation Capacity
-
- Adrián LLerena
- CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
-
- Pedro Dorado
- CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
-
- Eva M Peñas-Lledó
- CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
収録刊行物
-
- Pharmacogenomics
-
Pharmacogenomics 10 (1), 17-28, 2008-12-23
Informa UK Limited